Impact of prolonged treatment with high-dose ciprofloxacin on human gut flora: A case report

Journal of Medical Case Reports

Volumn 4, Issue , 2010, Pages

  Kourbeti, Irene S ^a   Alegakis, Dimitrios E ^a   Maraki, Sofia ^a   Samonis, George ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL OVERGROWTH; CASE REPORT; CAUCASIAN; COLON FLORA; COLONY FORMING UNIT; DIABETES MELLITUS; DISEASE DURATION; DRUG EFFECT; DRUG MEGADOSE; DRUG SENSITIVITY; ENTEROCOCCUS; FECES CULTURE; GRAM NEGATIVE BACTERIUM; HUMAN; LOW BACK PAIN; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PELVIS; PELVIS OSTEOMYELITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SACROILIAC JOINT; SACROILIITIS; TREATMENT DURATION; YEAST;

EID: 77951080825     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-4-111     Document Type: Article

References (11)

1. Quinolones. DC Hooper, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases Philadelphia: Churchill Livingstone, Mandell GL, Bennett JE, Dolin R, 2005 451 473
2. Effects of low levels of ciprofloxacin on a chemostat model of the human colonic microflora. RJ Carman MA Woodburn, Regul Toxicol Pharmacol 2001 33 276 284 10.1006/rtph.2001.1473 11407931
3. Chronic osteomyeltis caused by multi-resistant Gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow up. N Galanakis H Giamarellou T Moussas E Dounis, J Antimicrob Chemother 1997 39 241 246 10.1093/jac/39.2.241 9069546
4. Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute, 16th Informational Supplement. Approved Standard M100-S16. Wayne, Pennsylvania 2006
5. Effect of antimicrobial agents on the ecological balance of human microflora. A Sullivan C Edlund CE Nord, Lancet Infect Dis 2001 1 101 114 10.1016/S1473-3099(01)00066-4 11871461
6. Gut flora in health and disease. F Guarner JR Malagelada, Lancet 2003 361 512 519 10.1016/S0140-6736(03)12489-0 12583961
7. The effects of antibiotic use on gastrointestinal function. J Levy, Am J Gastroenterol 2000 95 Suppl 1 8 10 10.1016/S0002-9270(99)00808-4 10638552
8. Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections. E Mavromanolakis S Maraki G Samonis Y Tselentis A Cranidis, J Chemother 1997 9 203 207 9210003
9. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. C Edlund CE Nord, J Antimicrob Chemother 2000 46 Suppl 1 41 48 10.1093/jac/46.suppl-1.41
10. Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration with daily and weekly dosages. R Terg K Llano SM Cobas C Brotto A Barrios D Levi W Wasen MA Bartellini, J Hepatol 1998 29 437 442 10.1016/S0168-8278(98)80062-7 9764991
11. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. A Rolachon L Cordier Y Bacq JB Nousbaum A Franza JC Paris S Fratte B Bohn B Bohn P Kitmacher JP Stahl, Hepatol 1995 22 1171 1174